United States development
Interlune
Interlune is a Seattle-based company developing technology to extract helium-3 from the lunar regolith and return it to Earth for use in quantum computing, medical imaging (MRI), and potential future fusion energy applications.
- Founded
- 2022
- Headquarters
- Seattle, United States
- Ownership
- Private
- Last round
- Undisclosed round · $500K 2026-01
Quick Facts
About Interlune
Interlune is a Seattle-based company developing technology to extract helium-3 from the lunar regolith and return it to Earth for use in quantum computing, medical imaging (MRI), and potential future fusion energy applications. Founded in 2022 by former astronaut Chris Hadfield's son Evan Hadfield and Rob Meyerson (former president of Blue Origin), the company is backed by investors including Bill Gates and Chris Sacca's Lowercarbon Capital. Helium-3 is extraordinarily rare on Earth but abundant in lunar surface material due to decades of solar wind deposition.
Interlune's approach involves robotic extraction and processing of regolith before cryo-shipping the He-3 back to Earth. The company targets the near-term quantum computing and scientific research market before potentially scaling to fusion.
Funding history
3 events| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-01-13 | Undisclosed round | $500K | — Form D filed 2026-01-28 by Interlune Corp: $500K sold of a $5.0M offering (first sale 2026-01-13). | sec.gov |
| 2024-01-17 | Undisclosed round | $15.6M | — Form D filed 2024-02-01 by Interlune Corp: $15.6M sold of a $17.7M offering (first sale 2024-01-17). | sec.gov |
| 2022-08-03 | Undisclosed round | $1.9M | — Form D filed 2022-08-19 by Interlune Corp: $1.9M sold of a $2.6M offering (first sale 2022-08-03). | sec.gov |
Signals
- Verification
- Verified 2026-09-11
Categories & Capabilities
Industry Categories
Location
Loading map...
Share
Suggest an Edit
Is this information outdated or incorrect? Help us improve this profile.
Submit CorrectionExplore more
Search the full directory
Similar Companies
Other companies in lunar
Offworld
Offworld, founded in 2016 and based in Pasadena, California, is a robotics company focused on developing autonomous robo...
Venturi Astrolab
Venturi Astrolab, founded in 2019 and headquartered in Hawthorne, California, develops the FLEX Rover — a large-format l...
ispace
ispace is a Japanese lunar exploration company developing commercial lunar landers and transportation services. The comp...
Dymon
Dymon, founded in 2018 and based in Tokyo, Japan, is a space technology company focused on the development of lunar expl...
Spacebit
Spacebit is a UK-based space company founded in 2019 focused on lunar robotics and establishing a new economic model for...
Spartan Space
Spartan Space, founded in 2021 and based in Grenoble, France, is a space company focused on developing solutions for hum...
Also in United States
Other space companies based in United States
Frequently asked about Interlune
Quick answers to the questions readers most often search for.
- When was Interlune founded?
- Interlune was founded in 2022 in United States.
- Where is Interlune headquartered?
- Interlune is headquartered in Seattle, United States.
- What does Interlune do?
- Interlune is a Seattle-based company developing technology to extract helium-3 from the lunar regolith and return it to Earth for use in quantum computing, medical imaging (MRI), and potential future fusion energy applications. Founded in 2022 by former astronaut Chris Hadfield's son Evan Hadfield and Rob Meyerson (for…
- Is Interlune a public or private company?
- Interlune is a privately held company and is not listed on any stock exchange.
- What sector does Interlune operate in?
- Interlune works in lunar, Space resources and Robotics, plus 2 other space-industry sectors.
Data Accuracy Notice: Information about Interlune is compiled from publicly available sources including company websites, press releases, regulatory filings, and industry reports. Data is reviewed periodically but may not reflect the most recent developments.